Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-01-02
2007-01-02
Ceperley, Mary E. (Department: 1641)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S345000, C436S544000, C436S546000, C546S278700, C546S337000, C530S389800, C530S404000, C530S405000
Reexamination Certificate
active
10982611
ABSTRACT:
Activated haptens useful for generating immunogens to the HIV protease inhibitor atazanavir, immunogens useful for producing antibodies to atazanavir, and antibodies and labeled conjugates useful in immunoassays for determination of atazanavir. The haptens feature an activated functionality at the central, non-terminal hydroxyl group.
REFERENCES:
patent: 5302715 (1994-04-01), Buechler et al.
patent: 6087383 (2000-07-01), Singh et al.
patent: 2005/0244816 (2005-11-01), Valdez
patent: 1207394 (2002-02-01), None
patent: 2773994 (1999-07-01), None
patent: WO 95/23606 (1995-08-01), None
patent: WO 01/01135 (2001-01-01), None
patent: WO 03/048386 (2003-06-01), None
patent: WO 03/075009 (2003-09-01), None
Akeb, F. et al., “Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA,” Journal of Immunologial Methods 263 (2002) 1-9.
Eaglings, V.A. et al., “CPY3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro,” Xenobiotica, 2002. vol. 31, No. 1, 1-17.
Mansfeld, H-W et al., “Detection of inhibition of HIV-1 protease activity by an enzyme-linked immunosorbent assay (ELISA),” Journal of Immunological Methods, 161 (1993) 151-155.
Marzolini, C. et al., “Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction,” Journal of Chromatography B, 740, (2000) 43-58.
Poirier, J-M et al., “Simultaneous Determination of the Five HIV-Protease Inhibitors: Amprenavir, Indinavir, Nelfinavir, Ritonavir, and Saquinavir in Human Plasma by Solid-Phase Extraction and Column Liquid Chromatography,” Therapeutic Drug Monitoring, 22:465-473, 2000.
Remmel, R. et al., “Simultaneous HPLC Assay for Quantification of Indinavir, Nelfinavir, Ritonavir, and Saquinavir in Human Plasma,” Clinical Chemistry, 46:1, 73-81 (2000).
Sarubbi, E. et al., “A high throughput assay for inhibitors of HIV-1 protease, Screening of microbial metabolites,” FEBS 09419, vol. 279, No. 2, 265-269, (1991).
Valdez, H. et al., “Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen,” AIDS, 2000, vol. 14, No. 1, 11-21.
Wiltshire, H.R. et al., “Chromatographic and Immunochemical Approaches to the Analysis of the HIV Protease Inhibitor Saquinavir in Plasma,” Analytical Biochemistry, 281, 105-114 (2000).
Yu, S.-L. et al., “Assay of HIV-1 protease activity by use of crude preparations of enzyme and biotinlylated substrate,” Journal of Virological Methods, 53 (1995) 63-73.
Hui Raymond A.
Root Richard T.
Amick Marilyn L.
Ceperley Mary E.
Roche Diagnostics Operations Inc.
Roche Diagnostics Operations Inc.
LandOfFree
Methods of inhibiting transmission of a costimulatory signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting transmission of a costimulatory signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting transmission of a costimulatory signal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3770002